News
An extra five minutes of exercise per day could help to lower blood pressure – study

Adding small amounts of exercise into daily routine, such as climbing stairs or cycling to the shops, could help to reduce blood pressure, with just five additional minutes a day estimated to yield improvements, finds a new study from researchers at UCL and the University of Sydney.
The study, supported by the British Heart Foundation (BHF) and published in Circulation, analysed health data from 14,761 volunteers who wore activity trackers to explore the relationship between daily movement and blood pressure.
The researchers split daily activity into six behaviours including sleep, sedentary behaviour, standing and fast walking.
They then used this data to estimate the impact of replacing one type of activity with another.
They found that replacing any less active behaviour with five minutes of exercise could lower systolic blood pressure (SBP) by 0.68 millimetres of mercury (mmHg) and diastolic blood pressure (DBP) by 0.54mmHg2.
At a population level, a 2mmHg reduction in SBP and a 1mmHg reduction in DPB is equivalent to an approximately 10 per cent reduction in cardiovascular disease risk.
The study estimated that these ‘clinically meaningful’ improvements could be achieved with as little as 20 additional minutes of exercise per day for SBP and 10 additional minutes of exercise per day for DBP.
The findings emphasise that even everyday activities that raise heartrate, such as cycling, climbing stairs or short bursts of running, can have benefits for healthy blood pressure.
Dr Jo Blodgett is first author of the study from UCL Surgery & Interventional Science and the Institute of Sport, Exercise & Health.
The researcher said: “Our findings suggest that, for most people, exercise is key to reducing blood pressure, rather than less strenuous forms of movement such as walking.
“The good news is that whatever your physical ability, it doesn’t take long to have a positive effect on blood pressure.
“What’s unique about our exercise variable is that it includes all exercise-like activities, from climbing the stairs to a short cycling errand, many of which can be integrated into daily routines.
“For those who don’t do a lot of exercise, walking did still have some positive benefits for blood pressure.
“But if you want to change your blood pressure, putting more demand on the cardiovascular system through exercise will have the greatest effect.”
The researchers combined data from six studies in the ProPASS consortium, encompassing 14,761 people from five countries, to see how movement behaviour across the day is associated with blood pressure.
Each participant used a wearable accelerometer device on their thigh to measure their activity throughout the 24-hour day and had their blood pressure measured.
The average 24-hour day of the participants consisted of approximately seven hours of sleep, 10 hours of sedentary behaviour such as sitting, three hours of standing, one hour of slow walking, one hour of fast walking, and just 16 minutes of exercise activities such as running and cycling.
Using this data, the team modelled what would happen if an individual substituted various amounts of one behaviour for another each day, in order to estimate the effect on blood pressure of replacing one behaviour with another for a certain amount of time.
Professor Emmanuel Stamatakis is joint senior author of the study from the Charles Perkins Centre and Faculty of Medicine and Health at the University of Sydney.
Stamataki said: “High blood pressure is one of the biggest health issues globally, but there may be relatively accessible ways to tackle the problem in addition to medication.
“The finding that doing as little as five extra minutes of exercise or vigorous incidental activities per day could be associated with measurably lower blood pressure readings emphasises how powerful short bouts of higher intensity movement could be for blood pressure management.”
Hypertension, which describes consistently elevated blood pressure levels, affects 1.28 billion adults and is one of the biggest causes of premature death globally.
It can lead to stroke, heart attack, heart failure, kidney damage and many other health problems, and is often described as the ‘silent killer’ due to its lack of symptoms.
Professor Mark Hamer is joint senior author of the study from UCL Surgery & Interventional Science and the Institute of Sport, Exercise & Health.
He said: “Wearable activity-tracking devices such as smart watches, which are not dissimilar to the accelerometers used in this study, are becoming an increasingly important tools for patients to track their physical activity habits and manage risk factors such as high blood pressure.
“Our findings show how powerful research platforms like the ProPASS consortium are for identifying relatively subtle patterns of exercise, sleep, and sedentary behaviour, that have quite significant clinical and public health importance.”
Wellness
Gut-friendly foods may damage heart, charity warns
News
Diabetes patients face increased risk of undiagnosed heart failure

People with diabetes may have undiagnosed heart failure that could be detected by a simple screening blood test, research suggests.
The TARTAN-HF trial found that one in four patients with diabetes who had at least one other risk factor for heart failure had undiagnosed heart failure detected through screening with a blood test and ultrasound scanning of the heart.
Experts said the findings show the extent of unrecognised heart failure in people with diabetes, and how the condition can be detected using a widely available blood test called NT-proBNP, which measures how much strain the heart is under.
They suggest a heart failure screening programme for diabetics could improve diagnosis rates, lead to earlier treatment and potentially reduce the risk of hospitalisation and death.
The study, involving 700 patients, was led by the University of Glasgow in collaboration with AstraZeneca, Roche Diagnostics, Us2.ai, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
Dr Kieran Docherty, clinical senior lecturer at the University of Glasgow’s School of Cardiovascular and Metabolic Health, said: “Our results from the landmark TARTAN-HF trial identified heart failure in a large proportion of people living with diabetes, emphasising the need for a heart failure screening strategy in this group of patients.
“We know that many of the symptoms and signs of heart failure are non-specific, and may go unrecognised as potentially being due to heart failure for a long time.
“The strategy used in our trial is simple and easy to implement in clinical practice, and will aid in the early identification of heart failure in people with diabetes, and facilitate the initiation of medications that we know improve outcomes in patients with heart failure.”
The study, which began more than three years ago, involved more than 700 people with diabetes from the two health board areas who had at least one other risk factor for heart failure.
They were randomly assigned either to receive heart failure screening or to continue with their usual care.
Researchers found screening uncovered a large number of previously unrecognised cases of heart failure. Around one in four, or 24.9 per cent, of those screened were found to have the condition within six months, compared with 1 per cent in the group continuing their usual care.
The study, involving patients with type 1 and type 2 diabetes, found almost all of the participants found to have heart failure had preserved ejection fraction, which can be difficult to detect without dedicated testing.
The findings of the TARTAN-HF trial were presented at the American College of Cardiology conference taking place from 28 to 30 March in New Orleans in the US.
Dr Edward Piper, medical director at AstraZeneca UK, said: “Delayed diagnosis and treatment of heart failure in people with type 2 diabetes contributes to poor long-term outcomes. TARTAN-HF demonstrates that targeted, risk-based screening can identify previously undiagnosed heart failure in approximately one in four high-risk patients with diabetes, enabling earlier intervention with guideline-directed therapy.”
Dr Christian Simon, head of global medical affairs at Roche Diagnostics, said: “We are proud to have supported the landmark TARTAN-HF trial. These findings demonstrate the transformative power of early, accessible diagnostics like the NT-proBNP blood test.
“By identifying unrecognised heart failure in people with diabetes, we enable clinicians to initiate appropriate treatments sooner, ultimately improving patient outcomes and lives.”
News
UK government announces £6.3m fund to boost men’s health

The UK has launched a £6.3m men’s health fund to back local projects aimed at helping men and boys live longer, healthier lives.
The Men’s Health Community Fund is a partnership between the Department of Health and Social Care, Movember and People’s Health Trust.
The government is contributing £3m, while the two charities are more than doubling that to take the total to £6.3m.
Grants will support community projects reaching underserved men and boys aged 16 and over, particularly in the most disadvantaged areas and at key points in their lives such as becoming a father, losing a job or retiring.
Projects could include support for new fathers, activities for men facing loneliness and social isolation, services to help young men engage with the health system, and support for men in work, out of work and moving into retirement.
The programme will bring together voluntary, community and social enterprise organisations to test new ways of reaching men who are least likely to use traditional health services.
An evaluation funded through the National Institute for Health and Care Research will assess what works and help inform future policy and delivery.
Health and social care secretary Wes Streeting said: “Too many men across the country are living shorter, less healthy lives, particularly those in our most disadvantaged communities.
“This new partnership will help men get the support they need in the places they feel most comfortable, their communities, among people they trust.
“By working with expert charities and local organisations, we can reach the men who are too often missed by traditional services and help them take better care of their mental and physical health.”
“It is a key step in delivering our first ever Men’s Health Strategy and driving forward our ambition to halve the gap in healthy life expectancy between the richest and poorest areas.”
The Men’s Health Strategy sets out plans to tackle the physical and mental health challenges men and boys face.
Men can be less likely to seek help and more likely to suffer in silence, while higher rates of smoking, drinking, gambling and drug use are damaging men’s health and affecting families, workplaces and communities.
The government is also investing £3.6m over the next three years in suicide prevention projects for middle-aged men in local communities across areas of England where men are most at risk, many of which are also among the most deprived. Suicide is one of the biggest killers of men under 50, and three-quarters of all suicides are men.
The projects will aim to break down barriers middle-aged men face in seeking support, including stigma around asking for help and a lack of awareness of what is available and how to access it.
They will be co-designed with experts and men with lived experience of mental health crises and suicidal thoughts.












